CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,306 | -45.6% | 19,364 | -52.3% | 0.00% | – |
| Q1 2023 | $61,277 | -7.8% | 40,581 | -2.4% | 0.00% | – |
| Q4 2022 | $66,494 | +23.1% | 41,559 | +107.2% | 0.00% | – |
| Q1 2022 | $54,000 | -33.3% | 20,061 | +6.6% | 0.00% | – |
| Q4 2021 | $81,000 | -84.9% | 18,820 | -77.8% | 0.00% | – |
| Q2 2021 | $536,000 | +300.0% | 84,724 | +387.1% | 0.00% | – |
| Q1 2021 | $134,000 | +32.7% | 17,394 | +13.3% | 0.00% | – |
| Q4 2020 | $101,000 | -20.5% | 15,349 | -19.9% | 0.00% | – |
| Q3 2020 | $127,000 | -5.2% | 19,160 | +19.5% | 0.00% | – |
| Q2 2020 | $134,000 | – | 16,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |